Ironwood Pharmaceuticals (IRWD) Interest Coverage Ratio (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Interest Coverage Ratio across 17 years of filings, most recently posting 7.94 for Q1 2026.

• Interest Coverage Ratio for Q1 2026 came in at 7.94, up 320.11% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.44 (up 119.98% YoY), and the FY2025 annual result was 0.45, down 84.07% from the prior year.
• Interest Coverage Ratio came in at 7.94 for Q1 2026 at Ironwood Pharmaceuticals, up from 9.76 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 44.93 in Q3 2022 to a low of 588.66 in Q2 2023.
• The 5-year median for Interest Coverage Ratio is 4.07 (2023), against an average of 30.02.
• Across the five-year window, Interest Coverage Ratio surged 440.57% in 2022 and plunged 2434.34% in 2023, its largest moves.
• Ironwood Pharmaceuticals' Interest Coverage Ratio stood at 84.51 in 2022, then soared by 105.28% to 4.46 in 2023, then decreased by 20.84% to 3.53 in 2024, then plunged by 376.36% to 9.76 in 2025, then soared by 181.32% to 7.94 in 2026.
• The last three Interest Coverage Ratio figures came in at 7.94 (Q1 2026), 9.76 (Q4 2025), and 8.95 (Q3 2025), per Business Quant data.